Dexamethasone Sodium Phosphate 1 mg/mL Solution for Iontophoresis is a specialized liquid formulation designed for use in iontophoresis therapy. This method utilizes an electric current to enhance the transdermal delivery of medication, providing targeted treatment for conditions such as inflammation, arthritis, tendonitis, and bursitis.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dexamethasone Sodium Phosphate 1 mg/mL Solution for Iontophoresis is a specialized liquid formulation designed for use in iontophoresis therapy. This therapy utilizes a mild electric current to facilitate the transdermal delivery of dexamethasone, allowing the medication to penetrate the skin and reach targeted tissues beneath. Dexamethasone is a potent corticosteroid known for its strong anti-inflammatory and immunosuppressive properties.
The use of iontophoresis with dexamethasone is particularly beneficial for patients requiring localized treatment without the need for systemic administration, thereby minimizing potential systemic side effects. The electric current employed during iontophoresis enhances the absorption of the medication directly into the affected area, resulting in a more concentrated therapeutic effect at the site of injury or inflammation.
This formulation is commonly utilized in the management of conditions such as tendonitis, bursitis, plantar fasciitis, epicondylitis (tennis elbow), carpal tunnel syndrome, patellar tendonitis, and other localized inflammatory disorders. By delivering dexamethasone directly to the site of inflammation, patients often experience a reduction in pain and swelling, improved range of motion, and accelerated healing times.
For prescribers, this formulation offers a targeted therapeutic option for patients who may not tolerate oral corticosteroids or for whom oral therapy is contraindicated. It provides an alternative route of administration that can be seamlessly integrated into physical therapy regimens. It's important to assess each patient's medical history, current medications, and overall health status to determine the appropriateness of iontophoresis with dexamethasone.
Patients receiving this therapy should be advised on what to expect during the iontophoresis treatment, including the sensation of a mild tingling or warmth at the application site. The treatment is generally well-tolerated, but some individuals may experience skin irritation or redness at the site of application. It is essential to inform the healthcare provider of any adverse reactions or if symptoms persist or worsen.
Additionally, patients should be monitored for any potential side effects associated with corticosteroid therapy, even though the systemic absorption is minimal with iontophoresis. These side effects are rare but may include hormonal imbalances, changes in blood sugar levels, or suppression of the immune response. Keeping open communication with the healthcare provider ensures optimal treatment outcomes and addresses any concerns promptly.
If you have any questions about Dexamethasone Sodium Phosphate 1 mg/mL Solution for Iontophoresis, or if you're considering this therapy as a treatment option, please reach out to us. Our team of compounding pharmacists at Bayview Pharmacy is here to provide you with detailed information and support to meet your healthcare needs.
Dexamethasone Sodium Phosphate 1 mg/mL Solution for Iontophoresis is a specialized formulation designed to deliver dexamethasone, a potent corticosteroid, directly through the skin using an electric current. This method is particularly beneficial for localized treatment, offering targeted relief for conditions such as inflammation, pain, and other dermatological issues. However, like all medications, it is important to consider potential drug interactions that may affect the efficacy and safety of the treatment.
Patients and prescribers should be aware that dexamethasone, being a corticosteroid, can interact with a variety of medications. One of the primary concerns is the interaction with nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or aspirin, which can increase the risk of gastrointestinal bleeding. Additionally, concurrent use with anticoagulants like warfarin may enhance or diminish the anticoagulant effects, necessitating close monitoring of blood coagulation parameters.
Another significant interaction is with medications that induce or inhibit cytochrome P450 enzymes, particularly CYP3A4. Drugs such as rifampin, phenytoin, and carbamazepine can induce CYP3A4, potentially reducing the effectiveness of dexamethasone by increasing its metabolism. Conversely, inhibitors like ketoconazole and erythromycin may increase dexamethasone levels, heightening the risk of systemic side effects.
Patients taking other corticosteroids or immunosuppressive agents should use this formulation with caution, as it may potentiate the effects of these drugs, leading to an increased risk of infections or other immunosuppressive-related complications. Additionally, live vaccines should be avoided during treatment with dexamethasone due to the potential for a diminished immune response.
For patients with diabetes, it is important to note that corticosteroids can elevate blood glucose levels, necessitating adjustments in antidiabetic medications. Similarly, those with hypertension should be monitored closely, as dexamethasone can cause fluid retention and increase blood pressure.
Patients and prescribers should also consider the potential for interactions with herbal supplements and over-the-counter medications. For instance, St. John's Wort, a common herbal remedy, can induce CYP3A4 and reduce the effectiveness of dexamethasone. It is crucial to provide a comprehensive list of all medications and supplements to the healthcare provider to ensure safe and appropriate use of this iontophoresis solution.
If you have any questions or need further information regarding the use of Dexamethasone Sodium Phosphate 1 mg/mL Solution for Iontophoresis, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you with any concerns or inquiries you may have.
Dexamethasone Sodium Phosphate 1 mg/mL Solution for Iontophoresis is a specialized liquid formulation designed to enhance the delivery of dexamethasone, a potent corticosteroid, through the skin using iontophoresis. Iontophoresis is a non-invasive technique that employs a mild electric current to drive charged molecules of medication across the skin barrier, directly to the targeted area. This method is particularly beneficial for localized treatment, as it allows for the concentration of the drug in a specific area, minimizing systemic exposure and potential side effects.
The mechanism of action of dexamethasone involves its anti-inflammatory and immunosuppressive properties. By inhibiting the release of pro-inflammatory mediators and reducing the activity of immune cells, dexamethasone effectively decreases inflammation and pain in the affected tissues. This makes it an ideal choice for conditions that require targeted anti-inflammatory treatment, such as tendinitis, bursitis, and other musculoskeletal disorders. The iontophoresis process enhances the penetration of dexamethasone into the deeper layers of the skin and underlying tissues, ensuring that the medication reaches the site of inflammation more efficiently than traditional topical applications.
For patients, the use of Dexamethasone Sodium Phosphate 1 mg/mL Solution for Iontophoresis offers a convenient and painless alternative to oral or injectable corticosteroids. The treatment is typically administered in a clinical setting, where a healthcare professional applies the solution to the skin and uses a specialized iontophoresis device to deliver the medication. The procedure is generally well-tolerated, with minimal discomfort, and can be repeated as needed based on the patient's condition and response to therapy.
For prescribers, this formulation provides a targeted approach to managing inflammatory conditions, allowing for precise control over the dosage and delivery of dexamethasone. The iontophoresis technique reduces the risk of systemic side effects associated with oral corticosteroids, such as gastrointestinal disturbances and adrenal suppression, making it a safer option for patients who require long-term anti-inflammatory treatment. Additionally, the localized delivery of the medication can lead to faster relief of symptoms, improving patient outcomes and satisfaction.
If you have any questions about Dexamethasone Sodium Phosphate 1 mg/mL Solution for Iontophoresis or its use in treating specific conditions, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to make informed decisions about your treatment options.
This solution is used in iontophoresis therapy to facilitate the transdermal delivery of medication through the skin, offering targeted treatment for conditions such as pain management or localized drug delivery.
Iontophoresis uses an electric current to enhance the penetration of Dexamethasone Sodium Phosphate through the skin, allowing for effective delivery of the medication to the targeted area.
This formulation is commonly used for pain management, inflammation reduction, and localized drug delivery for various musculoskeletal conditions.
While generally safe, this medication should be used under the guidance of a healthcare professional, especially in individuals with certain medical conditions or those who are pregnant or breastfeeding.
The solution is applied to the skin, and an iontophoresis device is used to deliver a mild electric current, facilitating the absorption of the medication into the targeted area.
Some individuals may experience skin irritation or redness at the site of application. It is important to consult with a healthcare provider if any adverse effects occur.
The frequency of treatment depends on the condition being treated and should be determined by a healthcare professional. Typically, sessions may be scheduled several times a week.
It is important to discuss all medications and treatments with a healthcare provider to avoid potential interactions and ensure safe use.
If a session is missed, consult with your healthcare provider to determine the best course of action. Do not double up on treatments without professional guidance.
The solution should be stored at room temperature, away from direct sunlight and moisture, and out of reach of children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)